Li RR

ORCID: 0000-0002-7825-9288 · 2 papers in corpus
review 2024
BMC pharmacology & toxicology ·doi:10.1186/s40360-024-00767-1

BACKGROUND AND OBJECTIVE: Endometriosis and adenomyosis are two common diseases that impair women's health, and dienogest is one of the pharmacologic treatments which is the first-line therapeutic option for patients with pelvic pain and in…

article 2020
Zhonghua fu chan ke za zhi ·doi:10.3760/cma.j.cn112141-20191202-00654

More than one third of patients with pelvic endometriosis have concomitant DIE with a lower rate of preoperative diagnosis. Pelvic pains, bad movement of uterus and painful nodulirity around cervix suggest the presence of DIE.